<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SLP
Simulations Plus
$
()


  • Simulations Plus announces U.S. FDA renewed license to DILIsym platform

    4/4/2024 - 08:38am
  • Fly Intel: After-Hours Movers

    4/3/2024 - 19:10pm
  • Simulations Plus backs FY24 EPS view 66c-68c, consensus 66c

    4/3/2024 - 18:56pm
  • Simulations Plus reports Q2 EPS 20c, consensus 19c

    4/3/2024 - 18:55pm
  • FDA awards Simulations Plus a grant through proposal with University of Bath

    3/5/2024 - 09:11am
  • Simulations Plus management to meet with Oppenheimer

    2/28/2024 - 05:55am
  • Simulations Plus management to meet with Oppenheimer

    2/27/2024 - 04:55am
  • Simulations Plus management to meet with Oppenheimer

    2/20/2024 - 08:37am
  • Simulations Plus extends pact with Translational Toxicology Division at NIEHS

    2/15/2024 - 09:05am
  • Simulations Plus teams with NEU and The TIM Company through new FDA grant

    1/9/2024 - 08:37am
  • Simulations Plus price target raised by $1 at Craig-Hallum, here's why

    1/4/2024 - 08:58am
  • Fly Intel: After-Hours Movers

    1/3/2024 - 18:40pm
  • Simulations Plus names Will Frederick COO, Dan Szot CRO

    1/3/2024 - 16:09pm
  • Simulations Plus backs FY24 EPS view 66c-68c, consensus 67c

    1/3/2024 - 16:08pm
  • Simulations Plus reports Q1 EPS 10c, consensus 10c

    1/3/2024 - 16:07pm
dynamic_feed Breaking News